Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICU | US
-0.11
-2.59%
Healthcare
Biotechnology
30/06/2024
24/04/2026
4.13
4.33
4.40
4.05
SeaStar Medical Holding Corporation a medical device company develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
127.8%1 month
174.6%3 months
114.3%6 months
115.0%-
-
-
-0.46
0.91
-8.13
-
-
-
17.31M
17.31M
-
-
-
-
-
3.59
5.29
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.25
Range1M
2.72
Range3M
2.86
Rel. volume
0.48
Price X volume
514.68K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd | ENLV | Biotechnology | 0.8885 | 19.02M | -2.01% | n/a | 2.92% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.88 | 18.75M | -2.59% | n/a | 3.49% |
| PLUR | PLUR | Biotechnology | 3.345 | 18.30M | -2.76% | n/a | 30845.83% |
| DOMH | DOMH | Biotechnology | 2.89 | 18.14M | 0.00% | n/a | 7.66% |
| DarT Bioscience Inc | DARE | Biotechnology | 2.11 | 18.03M | -0.47% | 0.12 | 218.34% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.91 | 17.74M | 0.00% | n/a | 0.00% |
| Cingulate Inc. Common Stock | CING | Biotechnology | 5.47 | 16.65M | -2.67% | n/a | 10.72% |
| HCW Biologics Inc. Common Stock | HCWB | Biotechnology | 0.3756 | 16.39M | -8.23% | n/a | -159.13% |
| VistaGen Therapeutics Inc | VTGN | Biotechnology | 0.5939 | 16.07M | 4.19% | n/a | 1.90% |
| Aytu BioScience Inc | AYTU | Biotechnology | 2.52 | 15.50M | 0.00% | n/a | 54.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.27 | 699.77K | -6.62% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0055 | 507.18K | -37.50% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.13 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 114.27 | 72.80 | Riskier |
| Debt to Equity | -0.46 | -1.23 | Expensive |
| Debt to Assets | 0.91 | 0.25 | Expensive |
| Market Cap | 17.31M | 3.66B | Emerging |